374 related articles for article (PubMed ID: 29606096)
21. Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells.
Gonçalves V; Henriques AF; Pereira JF; Neves Costa A; Moyer MP; Moita LF; Gama-Carvalho M; Matos P; Jordan P
RNA; 2014 Apr; 20(4):474-82. PubMed ID: 24550521
[TBL] [Abstract][Full Text] [Related]
22. Alternative splicing of SLC39A14 in colorectal cancer is regulated by the Wnt pathway.
Thorsen K; Mansilla F; Schepeler T; Øster B; Rasmussen MH; Dyrskjøt L; Karni R; Akerman M; Krainer AR; Laurberg S; Andersen CL; Ørntoft TF
Mol Cell Proteomics; 2011 Jan; 10(1):M110.002998. PubMed ID: 20938052
[TBL] [Abstract][Full Text] [Related]
23. Kinase domain insertions define distinct roles of CLK kinases in SR protein phosphorylation.
Bullock AN; Das S; Debreczeni JE; Rellos P; Fedorov O; Niesen FH; Guo K; Papagrigoriou E; Amos AL; Cho S; Turk BE; Ghosh G; Knapp S
Structure; 2009 Mar; 17(3):352-62. PubMed ID: 19278650
[TBL] [Abstract][Full Text] [Related]
24. Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency.
Dahal S; Clayton K; Been T; Fernet-Brochu R; Ocando AV; Balachandran A; Poirier M; Maldonado RK; Shkreta L; Boligan KF; Guvenc F; Rahman F; Branch D; Bell B; Chabot B; Gray-Owen SD; Parent LJ; Cochrane A
Retrovirology; 2022 Aug; 19(1):18. PubMed ID: 35986377
[TBL] [Abstract][Full Text] [Related]
25. Mobilization of a splicing factor through a nuclear kinase-kinase complex.
Aubol BE; Keshwani MM; Fattet L; Adams JA
Biochem J; 2018 Feb; 475(3):677-690. PubMed ID: 29335301
[TBL] [Abstract][Full Text] [Related]
26. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20.
He X; Ee PL; Coon JS; Beck WT
Clin Cancer Res; 2004 Jul; 10(14):4652-60. PubMed ID: 15269137
[TBL] [Abstract][Full Text] [Related]
27. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
28. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
29. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
30. Release of SR Proteins from CLK1 by SRPK1: A Symbiotic Kinase System for Phosphorylation Control of Pre-mRNA Splicing.
Aubol BE; Wu G; Keshwani MM; Movassat M; Fattet L; Hertel KJ; Fu XD; Adams JA
Mol Cell; 2016 Jul; 63(2):218-228. PubMed ID: 27397683
[TBL] [Abstract][Full Text] [Related]
31. Cdc2-like kinases and DNA topoisomerase I regulate alternative splicing of tissue factor in human endothelial cells.
Eisenreich A; Bogdanov VY; Zakrzewicz A; Pries A; Antoniak S; Poller W; Schultheiss HP; Rauch U
Circ Res; 2009 Mar; 104(5):589-99. PubMed ID: 19168442
[TBL] [Abstract][Full Text] [Related]
32. Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases.
Aubol BE; Plocinik RM; Hagopian JC; Ma CT; McGlone ML; Bandyopadhyay R; Fu XD; Adams JA
J Mol Biol; 2013 Aug; 425(16):2894-909. PubMed ID: 23707382
[TBL] [Abstract][Full Text] [Related]
33. Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945.
Lee JY; Yun JS; Kim WK; Chun HS; Jin H; Cho S; Chang JH
Biomed Res Int; 2019; 2019():6125068. PubMed ID: 31531359
[TBL] [Abstract][Full Text] [Related]
34. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
Fedorov O; Huber K; Eisenreich A; Filippakopoulos P; King O; Bullock AN; Szklarczyk D; Jensen LJ; Fabbro D; Trappe J; Rauch U; Bracher F; Knapp S
Chem Biol; 2011 Jan; 18(1):67-76. PubMed ID: 21276940
[TBL] [Abstract][Full Text] [Related]
35. A conserved sequence motif bridges two protein kinases for enhanced phosphorylation and nuclear function of a splicing factor.
Aubol BE; Fattet L; Adams JA
FEBS J; 2021 Jan; 288(2):566-581. PubMed ID: 32359191
[TBL] [Abstract][Full Text] [Related]
36. Alternative splicing variants of dual specificity tyrosine phosphorylated and regulated kinase 1B exhibit distinct patterns of expression and functional properties.
Leder S; Czajkowska H; Maenz B; De Graaf K; Barthel A; Joost HG; Becker W
Biochem J; 2003 Jun; 372(Pt 3):881-8. PubMed ID: 12633499
[TBL] [Abstract][Full Text] [Related]
37. Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy.
Wong R; Balachandran A; Mao AY; Dobson W; Gray-Owen S; Cochrane A
Retrovirology; 2011 Jun; 8():47. PubMed ID: 21682887
[TBL] [Abstract][Full Text] [Related]
38. Regulation of pro-angiogenic tissue factor expression in hypoxia-induced human lung cancer cells.
Eisenreich A; Zakrzewicz A; Huber K; Thierbach H; Pepke W; Goldin-Lang P; Schultheiss HP; Pries A; Rauch U
Oncol Rep; 2013 Jul; 30(1):462-70. PubMed ID: 23604472
[TBL] [Abstract][Full Text] [Related]
39. An extensive program of periodic alternative splicing linked to cell cycle progression.
Dominguez D; Tsai YH; Weatheritt R; Wang Y; Blencowe BJ; Wang Z
Elife; 2016 Mar; 5():. PubMed ID: 27015110
[TBL] [Abstract][Full Text] [Related]
40. Conserved proline-directed phosphorylation regulates SR protein conformation and splicing function.
Keshwani MM; Aubol BE; Fattet L; Ma CT; Qiu J; Jennings PA; Fu XD; Adams JA
Biochem J; 2015 Mar; 466(2):311-22. PubMed ID: 25529026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
